Inogen (INGN) Competitors $6.80 0.00 (0.00%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$6.80 +0.00 (+0.07%) As of 07/25/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock INGN vs. SMLR, EMBC, CBLL, BVS, BBNX, AVNS, AXGN, KIDS, BFLY, and DCTHShould you be buying Inogen stock or one of its competitors? The main competitors of Inogen include Semler Scientific (SMLR), Embecta (EMBC), CeriBell (CBLL), Bioventus (BVS), Beta Bionics (BBNX), Avanos Medical (AVNS), AxoGen (AXGN), OrthoPediatrics (KIDS), Butterfly Network (BFLY), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. Inogen vs. Its Competitors Semler Scientific Embecta CeriBell Bioventus Beta Bionics Avanos Medical AxoGen OrthoPediatrics Butterfly Network Delcath Systems Inogen (NASDAQ:INGN) and Semler Scientific (NASDAQ:SMLR) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation. Does the media favor INGN or SMLR? In the previous week, Semler Scientific had 3 more articles in the media than Inogen. MarketBeat recorded 6 mentions for Semler Scientific and 3 mentions for Inogen. Inogen's average media sentiment score of 0.50 beat Semler Scientific's score of 0.45 indicating that Inogen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inogen 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Semler Scientific 0 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has stronger earnings & valuation, INGN or SMLR? Semler Scientific has lower revenue, but higher earnings than Inogen. Semler Scientific is trading at a lower price-to-earnings ratio than Inogen, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInogen$335.70M0.54-$35.89M-$1.15-5.91Semler Scientific$49.23M10.67$40.90M-$2.61-14.59 Do analysts rate INGN or SMLR? Inogen presently has a consensus price target of $11.00, indicating a potential upside of 61.76%. Semler Scientific has a consensus price target of $89.00, indicating a potential upside of 133.72%. Given Semler Scientific's stronger consensus rating and higher probable upside, analysts plainly believe Semler Scientific is more favorable than Inogen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inogen 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50Semler Scientific 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more risk and volatility, INGN or SMLR? Inogen has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500. Comparatively, Semler Scientific has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Do insiders & institutionals believe in INGN or SMLR? 89.9% of Inogen shares are owned by institutional investors. Comparatively, 49.4% of Semler Scientific shares are owned by institutional investors. 1.5% of Inogen shares are owned by company insiders. Comparatively, 30.2% of Semler Scientific shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Is INGN or SMLR more profitable? Inogen has a net margin of -8.08% compared to Semler Scientific's net margin of -60.69%. Semler Scientific's return on equity of 19.75% beat Inogen's return on equity.Company Net Margins Return on Equity Return on Assets Inogen-8.08% -14.76% -9.01% Semler Scientific -60.69%19.75%15.47% SummarySemler Scientific beats Inogen on 10 of the 17 factors compared between the two stocks. Get Inogen News Delivered to You Automatically Sign up to receive the latest news and ratings for INGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding INGN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INGN vs. The Competition Export to ExcelMetricInogenMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$182.83M$6.85B$5.70B$9.50BDividend YieldN/A1.27%4.60%4.01%P/E Ratio-5.9125.4528.1020.06Price / Sales0.5464.10429.3889.33Price / CashN/A20.5536.2258.56Price / Book0.934.758.665.87Net Income-$35.89M$176.14M$3.25B$258.55M7 Day Performance7.09%2.92%4.22%3.73%1 Month Performance-5.56%3.23%10.51%11.75%1 Year Performance-29.68%7.28%34.40%18.02% Inogen Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INGNInogen4.2487 of 5 stars$6.80flat$11.00+61.8%-29.9%$182.83M$335.70M-5.911,030SMLRSemler Scientific2.5959 of 5 stars$45.23-0.7%$89.00+96.8%+18.5%$619.20M$56.29M-17.33120EMBCEmbecta4.696 of 5 stars$10.37-1.0%$19.33+86.4%-26.1%$606.05M$1.08B11.522,100Positive NewsCBLLCeriBell2.3135 of 5 stars$16.38+1.5%$32.14+96.2%N/A$591.97M$65.44M0.00N/ABVSBioventus3.3542 of 5 stars$6.81-2.3%$13.75+101.9%-11.8%$559.40M$567.70M-11.161,200BBNXBeta BionicsN/A$12.83+1.3%$23.44+82.7%N/A$556.31M$65.12M0.00294News CoverageLockup ExpirationAVNSAvanos Medical2.9121 of 5 stars$11.85-0.6%N/A-47.6%$548.13M$687.80M-1.422,227News CoverageUpcoming EarningsAXGNAxoGen2.219 of 5 stars$12.02+1.1%$24.50+103.8%+43.3%$547.39M$187.34M-80.13450KIDSOrthoPediatrics4.2032 of 5 stars$22.14+1.1%$35.83+61.8%-30.8%$537.78M$204.73M-12.65200BFLYButterfly Network2.4812 of 5 stars$1.83+0.8%$3.50+91.8%+85.4%$451.30M$82.06M-6.29460News CoverageUpcoming EarningsDCTHDelcath Systems2.7352 of 5 stars$11.87+4.7%$24.00+102.2%+31.1%$413.43M$37.21M-23.7460News CoverageHigh Trading Volume Related Companies and Tools Related Companies Semler Scientific Alternatives Embecta Alternatives CeriBell Alternatives Bioventus Alternatives Beta Bionics Alternatives Avanos Medical Alternatives AxoGen Alternatives OrthoPediatrics Alternatives Butterfly Network Alternatives Delcath Systems Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:INGN) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhat I told my neighbor to do with his moneyWhen a close friend inherited money, Joel Litman gave him the same investment advice he gives his own mom. ...Altimetry | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inogen, Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Inogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INGN Stock Alerts